Rocket Lab earnings today: What to expect from Q3 results
Rocket Lab reports Q3 results today, with revenue expected at $250M-$265M and a loss of 7 cents per share. Analysts anticipate Q4 guidance near $265M, bringing annual revenue to ~$959M. The stock is up 9.7% recently but down 24% YTD. Neutron rocket delays and the $8B Iridium acquisition are key focus areas. Analysts' price targets range from $90 to $120, with 18 of 22 rating it a Buy.
How this was made
The 30-second read
Why it matters
The earnings miss and Neutron delay introduce short‑term downside risk, but the Iridium acquisition and strong backlog provide a longer‑term upside narrative.
Market read
First‑report earnings and a multi‑billion‑dollar acquisition create immediate trading opportunities in the aerospace and satellite sectors.
What to watch
Potential regulatory approvals for the Iridium acquisition and the impact of the $397M Space Force contract on cash flow.
Background
Rocket Lab's Q3 earnings release includes guidance, a major acquisition, and operational updates on its launch cadence.
Ticker impact
Rocket Lab reported Q3 earnings with a loss of 7¢ per share on $250‑$265M revenue and announced a delay of the Neutron rocket to 2027.
mixed pressure as investors weigh the earnings loss and Neutron delay against the Iridium acquisition and backlog strength
First‑report earnings with concrete numbers and a major M&A announcement create immediate trading considerations.
Iridium shareholders approved Rocket Lab's $8 billion acquisition, expected to close mid‑2027 and add $870 M annual revenue.
likely upside as the deal is priced at a premium to Iridium's current valuation
Deal terms disclosed for the first time; market will price in expected revenue accretion.
Market effects
Space launch sector may see heightened scrutiny on schedule reliability while consolidation accelerates.
U.S. aerospace and satellite communications stocks could experience spillover effects.
The Iridium deal signals further consolidation in the global satellite communications market.
Counterpoint
Investors may view the Neutron delay as a red flag for Rocket Lab's execution risk, outweighing acquisition benefits.
Key entities
- CompanyRocket Lab
U.S. aerospace launch provider reporting Q3 results.
- CompanyIridium Communications
Satellite communications firm being acquired by Rocket Lab.
